{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T17:56:04Z","timestamp":1774893364204,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>This review gathers all, to the best of our current knowledge, known lysins, mainly bacteriophage-derived, that have demonstrated activity against <jats:italic>Bacillus anthracis<\/jats:italic> strains. <jats:italic>B. anthracis<\/jats:italic> is a spore-forming, toxin-producing bacteria, naturally dwelling in soil. It is best known as a potential biowarfare threat, an etiological agent of anthrax, and a severe zoonotic disease. Anthrax can be treated with antibiotics (ciprofloxacin, penicillin, doxycycline); however, their administration may take up even to 60 days, and different factors can compromise their effectiveness. Bacterial viruses, bacteriophages (phages), are natural enemies of bacteria and use their lytic enzymes, endolysins (lysins), to specifically kill bacterial cells. Harnessing the potential of lysins to combat bacterial infections holds promise for diminishing antibiotic usage and, consequently, addressing the escalating antibiotic resistance in bacteria. In this context, we list the lysins with the activity against <jats:italic>B. anthracis<\/jats:italic>, providing a summary of their lytic properties in vitro and the outcomes observed in animal models. <jats:italic>Bacillus cereus<\/jats:italic> strain ATCC 4342\/RSVF1, a surrogate for <jats:italic>B. anthracis<\/jats:italic>, was also included as a target bacteria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Key points<\/jats:title>\n            <jats:p>\u2022\u00a0<jats:italic>More than a dozen different B. anthracis lysins have been identified and studied.<\/jats:italic>\n            <\/jats:p>\n            <jats:p>\u2022 <jats:italic>They fall into three blocks regarding their amino acid sequence similarity and most of them are amidases.<\/jats:italic>\n            <\/jats:p>\n            <jats:p>\u2022\u00a0<jats:italic>Lysins could be used in treating B. anthracis infections.<\/jats:italic>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00253-024-13194-3","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T10:01:23Z","timestamp":1717840883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lysins as a powerful alternative to combat Bacillus anthracis"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5184-3687","authenticated-orcid":false,"given":"Aleksandra","family":"Nakonieczna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2363-9988","authenticated-orcid":false,"given":"Karolina","family":"Abramowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6319-9411","authenticated-orcid":false,"given":"Magdalena","family":"Kwiatek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-8254","authenticated-orcid":false,"given":"Ewelina","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,8]]},"reference":[{"issue":"2","key":"13194_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/antibiotics10020124","volume":"10","author":"F Abdelrahman","year":"2021","unstructured":"Abdelrahman F, Easwaran M, Daramola OI, Ragab S, Lynch S, Oduselu TJ, Khan FM, Ayobami A, Adnan F, Torrents E, Sanmukh S, El-Shibiny A (2021) Phage-encoded endolysins. Antibiotics 10(2):124. https:\/\/doi.org\/10.3390\/antibiotics10020124","journal-title":"Antibiotics"},{"key":"13194_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-019-2745-x","volume":"37","author":"A Al Shoyaib","year":"2020","unstructured":"Al Shoyaib A, Archie SR, Karamyan VT (2020) Intraperitoneal route of drug administration: should it be used in experimental animal studies? Pharm Res 37:1\u201317. https:\/\/doi.org\/10.1007\/s11095-019-2745-x","journal-title":"Pharm Res"},{"key":"13194_CR3","doi-asserted-by":"publisher","first-page":"e01164","DOI":"10.1128\/genomeA.01164-17","volume":"6","author":"S Alkalay","year":"2018","unstructured":"Alkalay S, Sternberg S, Coppenhagen-Glazer S, Hazan R (2018) Complete genome sequences of three Bacillus anthracis bacteriophages. Genome Announc 6:e01164\u2013e01117. https:\/\/doi.org\/10.1128\/genomeA.01164-17","journal-title":"Genome Announc"},{"key":"13194_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1128\/9781555818388.ch27","volume-title":"Bacillus subtilis and other Gram-positive Bacteria: Biochemistry, Physiology, and Molecular Genetics","author":"AR Archibald","year":"1993","unstructured":"Archibald AR, Hancock IC, Harwood CR (1993) Cell wall structure, synthesis, and turnover. In: Sonenshein AL, Hoch JA, Losick R (eds) Bacillus subtilis and other Gram-positive Bacteria: Biochemistry, Physiology, and Molecular Genetics. ASM, Washington, DC, pp 381\u2013410. https:\/\/doi.org\/10.1128\/9781555818388.ch27"},{"issue":"1","key":"13194_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41522-022-00285-0","volume":"8","author":"S Arroyo-Moreno","year":"2022","unstructured":"Arroyo-Moreno S, Cummings M, Corcoran DB, Coffey A, McCarthy RR (2022) Identification and characterization of novel endolysins targeting Gardnerella vaginalis biofilms to treat bacterial vaginosis. NPJ Biofilms Microbiomes 8(1):1\u201312. https:\/\/doi.org\/10.1038\/s41522-022-00285-0","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"2","key":"13194_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3201\/eid0802.01-0521","volume":"8","author":"DM Bell","year":"2002","unstructured":"Bell DM, Kozarsky PE, Stephens DS (2002) Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 8(2):222. https:\/\/doi.org\/10.3201\/eid0802.01-0521","journal-title":"Emerg Infect Dis"},{"key":"13194_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jbiotec.2021.02.010","volume":"330","author":"A Bhagwat","year":"2021","unstructured":"Bhagwat A, Zhang F, Collins CH, Dordick JS (2021) Influence of bacterial culture medium on peptidoglycan binding of cell wall lytic enzymes. J Biotechnol 330:27\u201334. https:\/\/doi.org\/10.1016\/j.jbiotec.2021.02.010","journal-title":"J Biotechnol"},{"issue":"9","key":"13194_CR8","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3201\/eid2009.131481","volume":"20","author":"M Booth","year":"2014","unstructured":"Booth M, Donaldson L, Cui X, Sun J, Cole S, Dailsey S, Hart A, Johns N, McConnell P, McLennan T, Parcell B, Robb H, Shippey B, Sim M, Wallis C, Eichacker PQ (2014) Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009\u20132010. Emerg Infect Dis 20(9):1452. https:\/\/doi.org\/10.3201\/eid2009.131481","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"13194_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/mmi.14134","volume":"110","author":"SS Broendum","year":"2018","unstructured":"Broendum SS, Buckle AM, McGowan S (2018) Catalytic diversity and cell wall binding repeats in the phage-encoded endolysins. Mol Microbiol 110(6):879\u2013896. https:\/\/doi.org\/10.1111\/mmi.14134","journal-title":"Mol Microbiol"},{"issue":"5","key":"13194_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/s0924-8579(02)00200-5","volume":"20","author":"I Brook","year":"2002","unstructured":"Brook I (2002) The prophylaxis and treatment of anthrax. Int J Antimicrob Agents 20(5):320\u2013325. https:\/\/doi.org\/10.1016\/s0924-8579(02)00200-5","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"13194_CR11","doi-asserted-by":"publisher","first-page":"000616","DOI":"10.1099\/mgen.0.000616","volume":"7","author":"SA Bruce","year":"2021","unstructured":"Bruce SA, Huang YH, Kamath PL, Van Heerden H, Turner WC (2021) The roles of antimicrobial resistance, phage diversity, isolation source and selection in shaping the genomic architecture of Bacillus anthracis. Microb Genom 7(8):000616. https:\/\/doi.org\/10.1099\/mgen.0.000616","journal-title":"Microb Genom"},{"issue":"1","key":"13194_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-021-00485-0","volume":"20","author":"MK Dassanayake","year":"2021","unstructured":"Dassanayake MK, Khoo TJ, An J (2021) Antibiotic resistance modifying ability of phytoextracts in anthrax biological agent Bacillus anthracis and emerging superbugs: a review of synergistic mechanisms. Ann Clin Microbiol Antimicrob 20(1):1\u201336. https:\/\/doi.org\/10.1186\/s12941-021-00485-0","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"5","key":"13194_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/v10050276","volume":"10","author":"I Etobayeva","year":"2018","unstructured":"Etobayeva I, Linden SB, Alem F, Harb L, Rizkalla L, Mosier PD, Johnson AA, Temple L, Hakami RM, Nelson DC (2018) Discovery and biochemical characterization of PlyP56, PlyN74, and PlyTB40\u2014Bacillus specific endolysins. Viruses 10(5):276. https:\/\/doi.org\/10.3390\/v10050276","journal-title":"Viruses"},{"key":"13194_CR14","doi-asserted-by":"publisher","first-page":"109698","DOI":"10.1016\/j.enzmictec.2020.109698","volume":"142","author":"Y Fu","year":"2020","unstructured":"Fu Y, Liang L, Deng S, Wu Y, Yuan Y, Gao M (2020) Novel spore lytic enzyme from a Bacillus phage leading to spore killing. Enzyme Microb Technol 142:109698. https:\/\/doi.org\/10.1016\/j.enzmictec.2020.109698","journal-title":"Enzyme Microb Technol"},{"issue":"1","key":"13194_CR15","doi-asserted-by":"publisher","first-page":"e85972","DOI":"10.1371\/journal.pone.0085972","volume":"9","author":"HH Ganz","year":"2014","unstructured":"Ganz HH, Law C, Schmuki M, Eichenseher F, Calendar R, Loessner MJ, Getz WM, Korlach J, Beyer W, Klumpp J (2014) Novel giant siphovirus from Bacillus anthracis features unusual genome characteristics. PLoS ONE 9(1):e85972. https:\/\/doi.org\/10.1371\/journal.pone.0085972","journal-title":"PLoS ONE"},{"key":"13194_CR16","doi-asserted-by":"publisher","first-page":"675440","DOI":"10.3389\/fphar.2021.675440","volume":"12","author":"VS Gondil","year":"2021","unstructured":"Gondil VS, Chhibber S (2021) Bacteriophage and endolysin encapsulation systems: a promising strategy to improve therapeutic outcomes. Front Pharmacol 12:675440. https:\/\/doi.org\/10.3389\/fphar.2021.675440","journal-title":"Front Pharmacol"},{"issue":"2","key":"13194_CR17","doi-asserted-by":"publisher","first-page":"105844","DOI":"10.1016\/j.ijantimicag.2019.11.001","volume":"55","author":"VS Gondil","year":"2020","unstructured":"Gondil VS, Harjai K, Chhibber S (2020) Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections. Int J Antimicrob Agents 55(2):105844. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.11.001","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"13194_CR18","doi-asserted-by":"publisher","first-page":"e130687","DOI":"10.3201\/eid2002.130687","volume":"20","author":"KA Hendricks","year":"2014","unstructured":"Hendricks KA, Wright ME, Shadomy SV, Bradley JS, Morrow MG, Pavia AT, Rubinstein E, HoltyJ-EC, Messonnier NE, Smith TL, Pesik N, TreadwelL TA, Bower WA (2014) Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis 20(2):e130687. https:\/\/doi.org\/10.3201\/eid2002.130687","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 3","key":"13194_CR19","doi-asserted-by":"publisher","first-page":"S341","DOI":"10.1093\/cid\/ciac534","volume":"75","author":"K Hendricks","year":"2022","unstructured":"Hendricks K, Person MK, Bradley JS, Mongkolrattanothai T, Hupert N, Eichacker P, Friedlander AM, Bower WA (2022) Clinical features of patients hospitalized for all routes of anthrax, 1880\u20132018: a systematic review. Clin Infect Dis 75(Suppl 3):S341\u2013S353. https:\/\/doi.org\/10.1093\/cid\/ciac534","journal-title":"Clin Infect Dis"},{"issue":"3","key":"13194_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bbrc.2007.09.002","volume":"363","author":"H Kikkawa","year":"2007","unstructured":"Kikkawa H, Fujinami Y, Suzuki SI, Yasuda J (2007) Identification of the amino acid residues critical for specific binding of the bacteriolytic enzyme of \u03b3-phage, PlyG, to Bacillus anthracis. Biochem Biophys Res Commun 363(3):531\u2013535. https:\/\/doi.org\/10.1016\/j.bbrc.2007.09.002","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"13194_CR21","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3390\/antibiotics11121685","volume":"11","author":"CP Klimko","year":"2022","unstructured":"Klimko CP, Welkos SL, Shoe JL, Mou S, Hunter M, Rill NO, DeShazer D, Cote CK (2022) Efficacy of treatment with the antibiotic novobiocin against infection with Bacillus anthracis or Burkholderia pseudomallei. Antibiotics 11(12):1685. https:\/\/doi.org\/10.3390\/antibiotics11121685","journal-title":"Antibiotics"},{"issue":"6","key":"13194_CR22","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/ddr.21803","volume":"82","author":"TE Leonard","year":"2021","unstructured":"Leonard TE, Siratan E, Hartiadi LY, Crystalia AA (2021) Insights into antimicrobial peptides in fighting anthrax: a review. Drug Dev Res 82(6):754\u2013766. https:\/\/doi.org\/10.1002\/ddr.21803","journal-title":"Drug Dev Res"},{"issue":"1","key":"13194_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12929-023-00919-1","volume":"30","author":"H Liu","year":"2023","unstructured":"Liu H, Hu Z, Li M, Yang Y, Lu S, Rao X (2023) Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria. J Biomed Sci 30(1):29. https:\/\/doi.org\/10.1186\/s12929-023-00919-1","journal-title":"J Biomed Sci"},{"issue":"6","key":"13194_CR24","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1128\/IAI.01875-06","volume":"75","author":"CL Loving","year":"2007","unstructured":"Loving CL, Kennett M, Lee GM, Grippe VK, Merkel TJ (2007) Murine aerosol challenge model of anthrax. Infect Immun 75(6):2689\u20132698. https:\/\/doi.org\/10.1128\/IAI.01875-06","journal-title":"Infect Immun"},{"issue":"42","key":"13194_CR25","doi-asserted-by":"publisher","first-page":"35433","DOI":"10.1074\/jbc.M502723200","volume":"280","author":"LY Low","year":"2005","unstructured":"Low LY, Yang C, Perego M, Osterman A, Liddington RC (2005) Structure and lytic activity of a Bacillus anthracis prophage endolysin. J Biol Chem 280(42):35433\u201335439. https:\/\/doi.org\/10.1074\/jbc.M502723200","journal-title":"J Biol Chem"},{"issue":"39","key":"13194_CR26","doi-asserted-by":"publisher","first-page":"34391","DOI":"10.1074\/jbc.M111.244160","volume":"286","author":"LY Low","year":"2011","unstructured":"Low LY, Yang C, Perego M, Osterman A, Liddington R (2011) Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins. J Biol Chem 286(39):34391\u201334403. https:\/\/doi.org\/10.1074\/jbc.M111.244160","journal-title":"J Biol Chem"},{"issue":"1","key":"13194_CR27","doi-asserted-by":"publisher","first-page":"2175519","DOI":"10.1080\/21645515.2023.2175519","volume":"19","author":"F Mehmood Khan","year":"2023","unstructured":"Mehmood Khan F, Manohar P, Singh Gondil V, Mehra N, Kayode Oyejobi G, Odiwuor N, Ahmad T, Huang G (2023) The applications of animal models in phage therapy: an update. Hum Vaccin Immunother 19(1):2175519. https:\/\/doi.org\/10.1080\/21645515.2023.2175519","journal-title":"Hum Vaccin Immunother"},{"issue":"19","key":"13194_CR28","doi-asserted-by":"publisher","first-page":"5899","DOI":"10.1128\/AEM.02235-13","volume":"79","author":"KK Mehta","year":"2013","unstructured":"Mehta KK, Paskaleva EE, Azizi-Ghannad S, Ley DJ, Page MA, Dordick JS, Kane RS (2013) Characterization of AmiBA2446, a novel bacteriolytic enzyme active against Bacillus species. Appl Environ Microbiol 79(19):5899\u20135906. https:\/\/doi.org\/10.1128\/AEM.02235-13","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"13194_CR29","doi-asserted-by":"publisher","first-page":"e0008026","DOI":"10.1371\/journal.pntd.0008026","volume":"14","author":"M Nakanwagi","year":"2020","unstructured":"Nakanwagi M, Ario AR, Kwagonza L, Aceng FL, Mwesigye J, Bulage L, Buule J, Sendagal JN, Downing R, Zhu BP (2020) Outbreak of gastrointestinal anthrax following eating beef of suspicious origin: Isingiro District, Uganda, 2017. PLoS Negl Trop Dis 14(2):e0008026. https:\/\/doi.org\/10.1371\/journal.pntd.0008026","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"13194_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00253-023-12839-z","volume":"108","author":"A Nakonieczna","year":"2024","unstructured":"Nakonieczna A, Topolska-Wo\u015b A, \u0141obocka M (2024) New Bacteriophagederived lysins, LysJ and LysF, with the potential to control Bacillus anthracis. Appl Microbiol Biotechnol 108(1):1\u201314. https:\/\/doi.org\/10.1007\/s00253-023-12839-z","journal-title":"Appl Microbiol Biotechnol"},{"key":"13194_CR31","first-page":"658","volume":"62","author":"M Niemcewicz","year":"2006","unstructured":"Niemcewicz M, Bartoszcze M (2006) Applying macro restriction analysis and PCR in differentiating plasmid cured strains of Bacillus anthracis from transitional strains (Bacillus sp. Ba 813). Vet Med 62:658\u2013662","journal-title":"Vet Med"},{"issue":"2","key":"13194_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.tjem.2018.10.002","volume":"19","author":"V Ozer","year":"2019","unstructured":"Ozer V, Gunaydin M, Pasli S, Aksoy F, Gunduz A (2019) Gastrointestinal and cutaneous anthrax: case series. T J Emerg Med 19(2):76\u201378. https:\/\/doi.org\/10.1016\/j.tjem.2018.10.002","journal-title":"T J Emerg Med"},{"issue":"1","key":"13194_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41598-017-18535-z","volume":"8","author":"S Park","year":"2018","unstructured":"Park S, Jun SY, Kim CH, Jung GM, Son JS, Jeong ST, Yoon SJ, Lee SY, Kang SH (2018) Characterisation of the antibacterial properties of the recombinant phage endolysins AP50-31 and LysB4 as potent bactericidal agents against Bacillus anthracis. Sci Rep 8(1):18. https:\/\/doi.org\/10.1038\/s41598-017-18535-z","journal-title":"Sci Rep"},{"issue":"2","key":"13194_CR34","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jmb.2006.11.056","volume":"366","author":"CJ Porter","year":"2007","unstructured":"Porter CJ, Schuch R, Pelzek AJ, Buckle AM, McGowan S, Wilce MC, Rossjohn J, Russell R, Nelson D, Fischetti VA, Whisstock JC (2007) The 1.6 \u00c5 crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis. J Mol Biol 366(2):540\u2013550. https:\/\/doi.org\/10.1016\/j.jmb.2006.11.056","journal-title":"J Mol Biol"},{"issue":"5","key":"13194_CR35","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3390\/pathogens9050370","volume":"9","author":"V Savransky","year":"2020","unstructured":"Savransky V, Ionin B, Reece J (2020) Current status and trends in prophylaxis and management of anthrax disease. Pathogens 9(5):370. https:\/\/doi.org\/10.3390\/pathogens9050370","journal-title":"Pathogens"},{"issue":"6900","key":"13194_CR36","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nature01026","volume":"418","author":"R Schuch","year":"2002","unstructured":"Schuch R, Nelson D, Fischetti VA (2002) A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418(6900):884\u2013889. https:\/\/doi.org\/10.1038\/nature01026","journal-title":"Nature"},{"issue":"9","key":"13194_CR37","doi-asserted-by":"publisher","first-page":"e00003","DOI":"10.1128\/AEM.00003-19","volume":"85","author":"R Schuch","year":"2019","unstructured":"Schuch R, Pelzek AJ, Nelson DC, Fischetti VA (2019) The PlyB endolysin of bacteriophage vB_BanS_Bcp1 exhibits broad-spectrum bactericidal activity against Bacillus cereus sensu lato isolates. Appl Environ Microbiol 85(9):e00003\u201319. https:\/\/doi.org\/10.1128\/AEM.00003-19","journal-title":"Appl Environ Microbiol"},{"key":"13194_CR38","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3389\/fmicb.2018.02927","volume":"9","author":"J Seijsing","year":"2018","unstructured":"Seijsing J, Sobieraj AM, Keller N, Shen Y, Zinkernagel AS, Loessner MJ, Schmelcher M (2018) Improved biodistribution and extended serum half-life of a bacteriophage endolysin by albumin binding domain fusion. Front Microbiol 9:2927. https:\/\/doi.org\/10.3389\/fmicb.2018.02927","journal-title":"Front Microbiol"},{"issue":"2","key":"13194_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/1076629041310082","volume":"10","author":"A Severin","year":"2004","unstructured":"Severin A, Tabei K, Tomasz A (2004) The structure of the cell wall peptidoglycan of Bacillus cereus RSVF1, a strain closely related to Bacillus anthracis. Microb Drug Resist 10(2):77\u201382. https:\/\/doi.org\/10.1089\/1076629041310082","journal-title":"Microb Drug Resist"},{"key":"13194_CR40","unstructured":"Simonsen KA, Chatterjee K (2022) Anthrax. StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK507773\/ Accessed on January 2024"},{"issue":"11","key":"13194_CR41","doi-asserted-by":"publisher","first-page":"e0242657","DOI":"10.1371\/journal.pone.0242657","volume":"15","author":"AV Skorynina","year":"2020","unstructured":"Skorynina AV, Piligrimova EG, Kazantseva OA, Kulyabin V, Baicher SD, Ryabova NA, Shadrin AM (2020) Bacillus-infecting bacteriophage Izhevsk harbors thermostable endolysin with broad range specificity. PLoS ONE 15(11):e0242657. https:\/\/doi.org\/10.1371\/journal.pone.0242657","journal-title":"PLoS ONE"},{"issue":"1","key":"13194_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-12-33","volume":"12","author":"B Son","year":"2012","unstructured":"Son B, Yun J, Lim JA, Shin H, Heu S, Ryu S (2012) Characterization of LysB4, an endolysin from the Bacillus cereus-infecting bacteriophage B4. BMC Microbiol 12(1):1\u20139. https:\/\/doi.org\/10.1186\/1471-2180-12-33","journal-title":"BMC Microbiol"},{"issue":"3","key":"13194_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/antibiotics8030155","volume":"8","author":"SM Swift","year":"2019","unstructured":"Swift SM, Etobayeva IV, Reid KP, Waters JJ, Oakley BB, Donovan DM, Nelson DC (2019) Characterization of LysBC17, a lytic endopeptidase from Bacillus cereus. Antibiotics 8(3):155. https:\/\/doi.org\/10.3390\/antibiotics8030155","journal-title":"Antibiotics"},{"issue":"14","key":"13194_CR44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.00321-21","volume":"95","author":"R V\u00e1zquez","year":"2021","unstructured":"V\u00e1zquez R, Garc\u00eda E, Garc\u00eda P (2021) Sequence-function relationships in phage-encoded bacterial cell wall lytic enzymes and their implications for phage-derived product design. J Virol 95(14):10\u20131128. https:\/\/doi.org\/10.1128\/JVI.00321-21","journal-title":"J Virol"},{"key":"13194_CR45","doi-asserted-by":"publisher","first-page":"198489","DOI":"10.1016\/j.virusres.2021.198489","volume":"302","author":"X Wan","year":"2021","unstructured":"Wan X, Geng P, Sun J, Yuan Z, Hu X (2021) Characterization of two newly isolated bacteriophages PW2 and PW4 and derived endolysins with lysis activity against Bacillus cereus group strains. Virus Res 302:198489. https:\/\/doi.org\/10.1016\/j.virusres.2021.198489","journal-title":"Virus Res"},{"key":"13194_CR46","doi-asserted-by":"publisher","unstructured":"Welkos S, Bozue JA, Twenhafel N, Cote CK (2016) Animal models for the pathogenesis, treatment, and prevention of infection by Bacillus anthracis. Microbiol Spectr 269\u2013311. https:\/\/doi.org\/10.1128\/microbiolspec.TBS-0001-2012","DOI":"10.1128\/microbiolspec.TBS-0001-2012"},{"issue":"7","key":"13194_CR47","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1128\/JB.188.7.2711-2714.2006","volume":"188","author":"P Yoong","year":"2006","unstructured":"Yoong P, Schuch R, Nelson D, Fischetti VA (2006) PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis. J Bacteriol 188(7):2711\u20132714. https:\/\/doi.org\/10.1128\/JB.188.7.2711-2714.2006","journal-title":"J Bacteriol"},{"key":"13194_CR48","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3389\/fmicb.2016.00745","volume":"7","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Gao M (2016) Proteomic analysis of a novel Bacillus jumbo phage revealing glycoside hydrolase as structural component. Front Microbiol 7:745. https:\/\/doi.org\/10.3389\/fmicb.2016.00745","journal-title":"Front Microbiol"},{"key":"13194_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-12-297","volume":"12","author":"Y Yuan","year":"2012","unstructured":"Yuan Y, Peng Q, Gao M (2012) Characteristics of a broad lytic spectrum endolysin from phage BtCS33 of Bacillus thuringiensis. BMC Microbiol 12:1\u20139. https:\/\/doi.org\/10.1186\/1471-2180-12-297","journal-title":"BMC Microbiol"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-024-13194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-024-13194-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-024-13194-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T20:43:21Z","timestamp":1748378601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-024-13194-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["13194"],"URL":"https:\/\/doi.org\/10.1007\/s00253-024-13194-3","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,8]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"366"}}